{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:52:39Z","timestamp":1790646759493,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"22","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>It remains unknown whether the treatment of hypertension influences the mortality of patients diagnosed with coronavirus disease 2019 (COVID-19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This is a retrospective observational study of all patients admitted with COVID-19 to Huo Shen Shan Hospital. The hospital was dedicated solely to the treatment of COVID-19 in Wuhan, China. Hypertension and the treatments were stratified according to the medical history or medications administrated prior to the infection. Among 2877 hospitalized patients, 29.5% (850\/2877) had a history of hypertension. After adjustment for confounders, patients with hypertension had a two-fold increase in the relative risk of mortality as compared with patients without hypertension [4.0% vs. 1.1%, adjusted hazard ratio (HR) 2.12, 95% confidence interval (CI) 1.17\u20133.82, P = 0.013]. Patients with a history of hypertension but without antihypertensive treatment (n = 140) were associated with a significantly higher risk of mortality compared with those with antihypertensive treatments (n = 730) (7.9% vs. 3.2%, adjusted HR 2.17, 95% CI 1.03\u20134.57, P = 0.041). The mortality rates were similar between the renin\u2013angiotensin\u2013aldosterone system (RAAS) inhibitor (4\/183) and non-RAAS inhibitor (19\/527) cohorts (2.2% vs. 3.6%, adjusted HR 0.85, 95% CI 0.28\u20132.58, P = 0.774). However, in a study-level meta-analysis of four studies, the result showed that patients with RAAS inhibitor use tend to have a lower risk of mortality (relative risk 0.65, 95% CI 0.45\u20130.94, P = 0.20).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While hypertension and the discontinuation of antihypertensive treatment are suspected to be related to increased risk of mortality, in this retrospective observational analysis, we did not detect any harm of RAAS inhibitors in patients infected with COVID-19. However, the results should be considered as exploratory and interpreted cautiously.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaa433","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T07:29:36Z","timestamp":1588750176000},"page":"2058-2066","source":"Crossref","is-referenced-by-count":315,"title":["Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study"],"prefix":"10.1093","volume":"41","author":[{"given":"Chao","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"},{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-0192","authenticated-orcid":false,"given":"Yue","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"},{"name":"Huo shen shan Hospital , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"},{"name":"Huo shen shan Hospital , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Clinical Laboratory, Xijing Hospital , Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Nursing Center, Xijing Hospital , Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"ICU, Xijing Hospital , Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Pulmonary and Critical Care Medicine center, Xinqiao Hospital , Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Li","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Department of Critical Care Medicine, Jinling hospital , Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Yang","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Department of Gastroenterology, Xinqiao Hospital , Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Department of Cardiology, The 942 Hospital , Yinchuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Department of Cardiovascular Medicine, The 980 Hospital , Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Huo shen shan Hospital , Wuhan, China"},{"name":"Department of Pulmonary and Critical Care, The 905 Hospital of Shanghai , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruining","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"},{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"The Central Hospital of Wuhan, Tongji Medical College, Huazhong University , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Logistics Support, The 940 Hospital , Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-5479","authenticated-orcid":false,"given":"J William","family":"McEvoy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0758-3539","authenticated-orcid":false,"given":"Osama","family":"Soliman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W","family":"Serruys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National University of Ireland Galway , Galway, Ireland"},{"name":"NHLI, Imperial College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7076-1185","authenticated-orcid":false,"given":"Ling","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xijing Hospital , Changle West Road, Xi\u2019an, 710032, China"},{"name":"Huo shen shan Hospital , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"2022102509072100200_ehaa433-B1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2022102509072100200_ehaa433-B2","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2022102509072100200_ehaa433-B3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2022102509072100200_ehaa433-B4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","article-title":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","volume":"26","author":"Wu","year":"2020","journal-title":"Nat Med"},{"key":"2022102509072100200_ehaa433-B5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2022102509072100200_ehaa433-B6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"2022102509072100200_ehaa433-B7","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa311","article-title":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","author":"Nicin","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102509072100200_ehaa433-B8","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"2022102509072100200_ehaa433-B9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"2022102509072100200_ehaa433-B10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"2022102509072100200_ehaa433-B11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"2022102509072100200_ehaa433-B12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102509072100200_ehaa433-B13","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4812","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"2022102509072100200_ehaa433-B14"},{"key":"2022102509072100200_ehaa433-B15"},{"key":"2022102509072100200_ehaa433-B16","year":"2020"},{"key":"2022102509072100200_ehaa433-B17","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102509072100200_ehaa433-B18","first-page":"746","article-title":"An introduction to multiplicity issues in clinical trials: the what, why, when and how","volume":"46","author":"Li","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2022102509072100200_ehaa433-B19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2022102509072100200_ehaa433-B20","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"2022102509072100200_ehaa433-B21","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin\u2013angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102509072100200_ehaa433-B22","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"2022102509072100200_ehaa433-B23","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102509072100200_ehaa433-B24"},{"key":"2022102509072100200_ehaa433-B25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"key":"2022102509072100200_ehaa433-B26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"2022102509072100200_ehaa433-B27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"2022102509072100200_ehaa433-B28","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022102509072100200_ehaa433-B29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"2022102509072100200_ehaa433-B30","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/22\/2058\/46617559\/eurheartj_41_22_2058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/22\/2058\/46617559\/eurheartj_41_22_2058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T05:08:42Z","timestamp":1666674522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/22\/2058\/5851436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":30,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2020,6,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa433","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,7]]},"published":{"date-parts":[[2020,6,4]]}}}